Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Integration of Next-Generation Sequencing to Treat Acute Lymphoblastic Leukemia with Targetable Lesions: The St. Jude Children’s Research Hospital Approach

4 Dec 2017

Abstract excerpt

Acute lymphoblastic leukemia (ALL) is the most common type of cancer in children. In recent Total Therapy studies conducted at St. Jude Children's Research Hospital, children with ALL had a 5-year overall survival of around 94%. This is the result of a combination of risk stratification based on the biological features of the leukemic cells and the response to treatment (as assessed by the detection of minimal...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Acute Lymphoblastic Leukemia research
Share to Acute Myeloid Leukemia Research
Share to Childhood Cancer Survivors' Quality of Life

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Source

Identifiers

PMID: 29255701
DOI: 10.3389/fped.2017.00258

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 8 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Integration of Next-Generation Sequencing to Treat Acute Lymphoblastic Leukemia with Targetable Lesions: The St. Jude Children’s Research Hospital ApproachPMID 29255701Read ↗

Next-Generation Sequencing in Acute Lymphoblastic LeukemiaSemantic proximity Read ↗

Childhood acute lymphoblastic leukemia: Integrating genomics into therapy.Semantic proximity Read ↗

Application of Next-Generation Sequencing-Based Mutational Profiling in Acute Lymphoblastic Leukemia.Semantic proximity Read ↗

Novel Biomarkers and Molecular Targets in ALL.Semantic proximity Read ↗

Redefining ALL classification: toward detecting high-risk ALL and implementing precision medicineSemantic proximity Read ↗

Pediatric acute lymphoblastic leukemia: where are we going and how do we get there?Semantic proximity Read ↗

Genomics in acute lymphoblastic leukaemia: insights and treatment implications.Semantic proximity Read ↗

Advances in the Biology of Acute Lymphoblastic Leukemia—From Genomics to the ClinicSemantic proximity Read ↗

Molecular genetics of acute lymphoblastic leukemia.Semantic proximity Read ↗

Genetic Biomarkers and Their Clinical Implications in B-Cell Acute Lymphoblastic Leukemia in Children.Semantic proximity Read ↗

New Challenges in Targeting Signaling Pathways in Acute Lymphoblastic Leukemia by NGS Approaches: An UpdateSemantic proximity Read ↗

Genomic characterization of paediatric acute lymphoblastic leukaemia: an opportunity for precision medicine therapeutics.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.